Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

NCT05342636

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • Liga Norte Riograndense Contra o Câncer ( Site 2303) Natal, Rio Grande do Norte, Brazil
  • Hospital Nossa Senhora da Conceição ( Site 2301) Porto Alegre, Rio Grande do Sul, Brazil
  • ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO ( Site 2300) São Paulo, Brazil
  • FALP-UIDO ( Site 2400) Santiago, Region M. de Santiago, Chile
View all 46 locations
View Trial Details
Completed

Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors

NCT04349267

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +22 more
Locations
  • Local Institution - 0028 Sioux Falls, South Dakota, United States
  • Local Institution - 0001 Germantown, Tennessee, United States
  • Local Institution - 0014 Edmonton, Alberta, Canada
  • Local Institution - 0011 Vancouver, British Columbia, Canada
View Trial Details
Completed

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

NCT05908786

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • University of Southern California (USC) Los Angeles, California, United States
  • University of California Los Angeles (UCLA) - Cancer Care - Santa Monica Santa Monica, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus Detroit, Michigan, United States
View all 30 locations
View Trial Details
Completed

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC

NCT04811027

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +6 more
Locations
  • University of Alabama at Birmingham (UAB) - O'Neal Cancer Center Birmingham, Alabama, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Oncology Consultants Houston, Texas, United States
  • Macquarie University Hospital Macquarie Park, New South Wales, Australia
View all 28 locations
View Trial Details

Related conditions